Abstract
This article explains how the venture business acts as a catalyst in the evolution of DDS contract research and development companies with special technology in a DDS field. The venture business prepares the DDS contract company for their research and development collaborations with pharmaceutical companies. The article is based on a large DDS database created in 1980, and maintained daily to date, involving DDS companies, venture capital, technologies and collaborations in drug delivery R&D.
